InspireMD Inc. NSPR recently announced the first patient enrolment in the company’s CGUARDIANS II clinical trial. The trial ...

InspireMD, Inc. announced that the first patient has been enrolled in the company’s CGUARDIANS II clinical trial evaluati ...

The District Consumer Disputes Redressal Commission-III, Hyderabad recently directed a hospital, and two associated doctors ...

It was essential for him to undergo stenting – a procedure to insert stents to keep open the blocked blood vessels. There were long waiting lists at state hospitals and in the private sector his ...

Amid ongoing violence, several Bangladeshi patients seeking medical treatment in Kolkata find themselves stranded. With unsafe travel conditions, many are stuck in hotels or with relatives, postponing ...

The practice of private hospitals organising medical camps to get more inpatients has come into focus with the death of four ...

DUBLIN--(BUSINESS WIRE)--The "Gastrointestinal Endoscopic Devices Market Size, Share & Trends Analysis | Europe | 2025-2031 | MedSuite | Includes: Stenting and Dilation Devices, FIT-DNA Tests ...

MIAMI, Nov. 25, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent ...

The adoption of minimally invasive technologies is driving innovation and market demand. Procedures such as endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) are gaining ...

Restenosis after carotid artery stenting (CAS) is associated with the risk of developing ischemic stroke. We aimed to evaluate the inhibitory effect of cilostazol addition on in-stent restenosis (ISR) ...

Opportunities to improve or optimize radial access for peripheral artery disease and embolization include additions and ...